Results 141 to 150 of about 6,525 (155)

Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration

Survey of Ophthalmology, 2000
Ursula Schmidt-Erfurth, Tayyaba Hasan
exaly  

In vitro and in vivo activities of verteporfin-loaded nanoparticles

Journal of Controlled Release, 2005
R Boch, Robert Gurny, Eric Allemann
exaly  

Verteporfin

Reactions Weekly, 2010
openaire   +1 more source

Verteporfin based silica nanoplatform for photodynamic therapy

ChemistrySelect, 2016
Enrica Gianotti, Ivana Miletto, Stelvio Tonello   +2 more
exaly  

Verteporfin

Reactions Weekly, 2009
openaire   +2 more sources

Evaluation of nanoencapsulated verteporfin’s cytotoxicity using a microfluidic system

Journal of Pharmaceutical and Biomedical Analysis, 2016
Katarzyna Tokarska, Urszula Bazylińska, Elżbieta Jastrzębska   +2 more
exaly  

Verteporfin

Reactions Weekly, 2003
openaire   +1 more source

Verteporfin ocular photodynamic therapy

Expert Opinion on Pharmacotherapy, 2004
Sophie J Bakri, Peter K Kaiser
exaly  

Verteporfin

Reactions Weekly
openaire   +1 more source

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

ChemMedChem, 2017
Fabrice Bailly, Matthieu Corvaisier, Mathilde Coevoet   +2 more
exaly